Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (131-140 of 333) with videos related to

Pageof 34
Sort By:
Cancer Research|November 1, 1973
Chemotherapy of malignant lymphoma with adriamycinJ A Gottlieb, J U Gutterman, K B McCredie, et al.
Cancer|February 1, 1987
Therapy of chronic myelogenous leukemiaM Talpaz, H Kantarjian, K McCredie, et al.
Leukemia Research|January 1, 1986
The c-abl, bcr and C lambda genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myelogenous leukemiaM B Blick, B S Andersson, J U Gutterman, et al.
Surgery, Gynecology & Obstetrics|March 1, 1975
Subpopulations of thymus dependent and thymus independent lymphocytes in human gut associated lymphoid tissuesG M Mavligit, A Jubert, J U Gutterman, et al.
American Journal of Hematology|September 1, 1988
Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemiaJ R Quesada, R Alexanian, R Kurzrock, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Evaluation of therapy with methanol extraction residue of BCG (MER)E M Hersh, J Quesada, S G Murphy, et al.
Acta Haematologica|January 1, 1990
Alpha interferon dose-dependent suppression of secondary clones in a patient with Philadelphia-positive chronic myelogenous leukemiaD Claxton, H Kantarjian, R Kurzrock, et al.
Blood|November 1, 1991
Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progressionM Wetzler, R Kurzrock, D G Lowe, et al.
Nature: New Biology|June 6, 1973
Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivityG M Mavligit, U Ambus, J U Gutterman, et al.
Experimental Hematology|June 1, 1991
Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-alpha, and TGF-betaM Wetzler, M Talpaz, D G Lowe, et al.
Pageof 34

Showing results (131-140 of 333) with videos related to

Sort By:
Pageof 34
Cancer Research|November 1, 1973
Chemotherapy of malignant lymphoma with adriamycinJ A Gottlieb, J U Gutterman, K B McCredie, et al.
Cancer|February 1, 1987
Therapy of chronic myelogenous leukemiaM Talpaz, H Kantarjian, K McCredie, et al.
Leukemia Research|January 1, 1986
The c-abl, bcr and C lambda genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myelogenous leukemiaM B Blick, B S Andersson, J U Gutterman, et al.
Surgery, Gynecology & Obstetrics|March 1, 1975
Subpopulations of thymus dependent and thymus independent lymphocytes in human gut associated lymphoid tissuesG M Mavligit, A Jubert, J U Gutterman, et al.
American Journal of Hematology|September 1, 1988
Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemiaJ R Quesada, R Alexanian, R Kurzrock, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Evaluation of therapy with methanol extraction residue of BCG (MER)E M Hersh, J Quesada, S G Murphy, et al.
Acta Haematologica|January 1, 1990
Alpha interferon dose-dependent suppression of secondary clones in a patient with Philadelphia-positive chronic myelogenous leukemiaD Claxton, H Kantarjian, R Kurzrock, et al.
Blood|November 1, 1991
Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progressionM Wetzler, R Kurzrock, D G Lowe, et al.
Nature: New Biology|June 6, 1973
Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivityG M Mavligit, U Ambus, J U Gutterman, et al.
Experimental Hematology|June 1, 1991
Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-alpha, and TGF-betaM Wetzler, M Talpaz, D G Lowe, et al.
Pageof 34